Literature DB >> 12090340

The prognostic value of proliferating cell nuclear antigen, Ki-67 and nucleolar organizer region in transitional cell carcinoma of the bladder.

Murat Bozlu1, Diclehan Orhan, Sümer Baltaci, Onder Yaman, Atilla Halil Elhan, Ozden Tulunay, Yusuf Ziya Müftüoğlu.   

Abstract

OBJECTIVES: To investigate the value of proliferating cell nuclear antigen (PCNA), Ki-67 antigen labelling indices and nucleolar organizer region (NOR) score in relation to histological grade, stage, recurrence and progression of the bladder tumor.
MATERIALS AND METHODS: Tissue specimens from 77 bladder cancer patients (43 superficial, 34 invasive) were immunostained with PCNA and Ki-67 and stained with AgNOR. Thirteen specimens of normal bladder mucosa served as controls.
RESULTS: In comparison to normal bladder mucosa the values of the three indicators were significantly greater (p < 0.001). There was a significant relationship between PCNA, Ki-67 indices, AgNOR scores and grade and stage of the tumor (p < 0.001). All indicators also correlated with each other (p < 0.001). The Kaplan-Meier curves for recurrence-progression free survival revealed that patients with a PCNA labelling index >36.22%, Ki-67 labelling index >29.68% and AgNOR score > 3.34 had a worse prognosis than those with <36.22%, <29.68% and <3.34, respectively.
CONCLUSIONS: PCNA, Ki-67 indices and AgNOR scores correlated with each other and with tumor grade and stage. These proliferation markers may give objective and accurate information about the biological behavior of bladder transitional cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12090340     DOI: 10.1023/a:1014452902976

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  24 in total

1.  Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.

Authors:  M Tomobe; T Shimazui; K Uchida; S Hinotsu; H Akaza
Journal:  J Urol       Date:  1999-07       Impact factor: 7.450

2.  Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level.

Authors:  D Ploton; M Menager; P Jeannesson; G Himber; F Pigeon; J J Adnet
Journal:  Histochem J       Date:  1986-01

3.  Investigation of p53, c-erbB-2, PCNA immunoreactivity, DNA content, AgNOR and apoptosis in bladder carcinoma as prognostic parameters.

Authors:  M Koyuncuoğlu; A Kargi; S Cingöz; Z Kirkali
Journal:  Cancer Lett       Date:  1998-04-24       Impact factor: 8.679

4.  Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours?

Authors:  D Plastiras; G Moutzouris; C Barbatis; V Presvelos; M Petrakos; C Theodorou
Journal:  Eur J Surg Oncol       Date:  1999-02       Impact factor: 4.424

5.  AgNOR counts and histological grade in stage pTa bladder tumours: reproducibility and relation to recurrence pattern.

Authors:  A B Hansen; B Bjerregaard; H Ovesen; T Horn
Journal:  Histopathology       Date:  1992-03       Impact factor: 5.087

6.  Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder.

Authors:  P Gontero; G Casetta; A Zitella; R Ballario; D Pacchioni; C Magnani; G H Muir; A Tizzani
Journal:  Eur Urol       Date:  2000-09       Impact factor: 20.096

7.  Expression of immunohistochemical markers (PCNA, Ki-67, 486p and p53) on paraffin sections and their relation to the recurrence rate of superficial bladder tumors.

Authors:  R Vorreuther; R Hake; P Borchmann; S Lukowsky; J Thiele; U Engelmann
Journal:  Urol Int       Date:  1997       Impact factor: 2.089

8.  Immunohistochemical studies of proliferating cell nuclear antigen and cathepsin D in transitional cell carcinoma of the urinary bladder.

Authors:  T Iizumi; T Iiyama; W Tanaka; E Okada; Y Kamiyama; Y Okano; S Sato; T Yazaki; T Umeda; T Imamura
Journal:  Urol Int       Date:  1997       Impact factor: 2.089

9.  Usefulness of MIB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma: comparison with Ki-67 antibody.

Authors:  C Mazerolles; P Rishmann; D Chopin; Z Popov; B Malavaud; J Selves; I Neulat-Duga; J Bellot; G Delsol
Journal:  Histopathology       Date:  1994-12       Impact factor: 5.087

10.  Superficial bladder cancer: progression and recurrence.

Authors:  N M Heney; S Ahmed; M J Flanagan; W Frable; M P Corder; M D Hafermann; I R Hawkins
Journal:  J Urol       Date:  1983-12       Impact factor: 7.450

View more
  3 in total

1.  Relationship of PCNA, C-erbB2 and CD44s expression with tumor grade and stage in urothelial carcinomas of the bladder.

Authors:  Ayhan Yıldırım; Mustafa Kösem; Ilyas Sayar; Ibrahim Gelincik; Alparslan Yavuz; Aliseydi Bozkurt; Unal Erkorkmaz; Irfan Bayram
Journal:  Int J Clin Exp Med       Date:  2014-06-15

Review 2.  High Ki-67 Immunohistochemical Reactivity Correlates With Poor Prognosis in Bladder Carcinoma: A Comprehensive Meta-Analysis with 13,053 Patients Involved.

Authors:  Yihuan Luo; Xin Zhang; Meile Mo; Zhong Tan; Lanshan Huang; Hong Zhou; Chunqin Wang; Fanglin Wei; Xiaohui Qiu; Rongquan He; Gang Chen
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

3.  Biomarkers of tumor invasiveness in proteomics (Review).

Authors:  Daniel L Pouliquen; Alice Boissard; Olivier Coqueret; Catherine Guette
Journal:  Int J Oncol       Date:  2020-05-28       Impact factor: 5.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.